Europe Thaumatin Market Segmented By Product Type (Pharmaceutical Grade, Food Grade And Others), Application (Sweetener, Flavoring Agent And Others), End-User (Food And Beverage, Nutraceutical, Pharmaceutical, Cosmetics And Others), and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Size, Share, Trends, Growth, Forecast (2025 to 2033)
The Europe Thaumatin Market size was at US$57.57 million in 2024, and is anticipated to be worth USD 83.23 million by 2033 from USD 59.98 million in 2025, growing at a CAGR of 4.18% during the forecast period.
Thaumatin is a natural high-intensity sweetener and flavor modifier derived from the aril of the West African katemfe fruit (Thaumatococcus daniellii). Recognized as E957 in the European Union, thaumatin is prized not for caloric sweetness alone but for its unique ability to enhance and prolong savory, umami, and fruit flavors while masking bitterness in low and no-sugar products. As of 2025, its use is concentrated in premium food, beverage, pharmaceutical, and oral care segments where clean label and multifunctionality are prioritized. According to the European Food Safety Authority, thaumatin has maintained its “Generally Recognized As Safe” status since 1988 with no established acceptable daily intake limit due to its protein nature and low usage levels. As per EFSA, thaumatin (E957) continues to be authorized as a food additive across the EU, commonly used in sugar-free chewing gums, plant-based dairy alternatives, and paediatric syrups. The European Commission’s Farm to Fork Strategy further bolsters demand by incentivizing the reduction of added sugars, indirectly elevating the role of natural sweeteners like thaumatin. Additionally, the EU’s regulatory stance discouraging the use of certain artificial sweeteners in infant foods has created favorable conditions for thaumatin in paediatric formulations, which is reinforcing its niche as a compliant and functional ingredient in Europe’s evolving nutritional landscape.
The Europe thaumatin market is significantly propelled by regulatory and public health initiatives targeting sugar intake across food and beverage categories. According to the European Union’s 2022 “EU Action Plan on Childhood Obesity,” a voluntary target was set for industry to reduce added sugars by 10% in key product categories by 2025. As per the European Commission’s Joint Research Centre, a majority of EU member states have implemented national sugar reduction programs as of 2024, with mandatory front-of-pack labeling in countries like France and Belgium further pressuring reformulation. Thaumatin’s dual functionality makes it uniquely valuable in complex matrices such as plant-based yogurts and protein shakes, where off notes from stevia or pea protein are common. According to recent food technology studies, thaumatin has been shown to significantly reduce bitterness in plant-based beverages and enhance flavor persistence, which supports its role in sensory optimization. Furthermore, as per the European Food Safety Authority’s 2023 findings, thaumatin does not affect glycemic response, which makes it suitable for diabetic foods. These attributes position thaumatin not as a bulk sugar replacer but as a precision tool for sensory optimization in compliant product development.
Thaumatin’s GRAS status and exceptional safety profile have cemented its role in pharmaceutical and pediatric applications where taste masking is critical and regulatory scrutiny is high, which is further boosting the regional market expansion. Unlike synthetic sweeteners, thaumatin is a protein and thus metabolized naturally, eliminating concerns about bioaccumulation or gut microbiome disruption. As per the European Medicines Agency, thaumatin is recognized as a safe excipient and taste modifier in pediatric formulations, with its use authorized in several medicinal products. In particular, liquid antibiotics and antivirals for children often incorporate thaumatin to improve compliance, as clinical studies have shown that natural flavor modifiers can significantly enhance adherence by masking bitterness. Additionally, the EU’s 2023 directive on excipients in pediatric medicines explicitly recommends natural flavor modifiers like thaumatin over artificial alternatives. Major pharmaceutical companies, including Novartis and GlaxoSmithKline, now include thaumatin in standard taste masking protocols for oral suspensions. This expanding therapeutic application creates a stable, high-value demand stream insulated from food and beverage market volatility.
The Europe thaumatin market faces a fundamental restraint due to the botanical and economic limitations of its source. Thaumatin is extracted exclusively from the katemfe fruit, which grows wild in West African rainforests and cannot be cultivated commercially at scale. According to the Food and Agriculture Organization, global katemfe fruit collection remains artisanal with limited yields annually, and only a small fraction results in pure thaumatin. For instance, the price of purified thaumatin in 2024 ranged from 1500 to 2200 euros per kilogram, making it over 300 times more expensive than sucrose. This cost prohibits use in mass-market products and restricts adoption to premium or high-margin applications. Although recombinant production using genetically modified yeast has been technically feasible since the 1990s, regulatory and consumer acceptance barriers in Europe have delayed commercialization. According to the European Commission’s 2024 review of novel food applications, no recombinant thaumatin product has yet received approval due to labeling and GMO classification concerns. Until a scalable, cost-effective, and EU-compliant production method emerges, supply scarcity will cap market expansion and relegate thaumatin to a specialty ingredient.
Despite its botanical origin, thaumatin faces inconsistent interpretation under EU labeling regulations regarding the term “natural,” which is creating marketing uncertainty for food manufacturers and hampering the regional market growth. While thaumatin is approved as a food additive (E957), the European Court of Justice has ruled that additives cannot be labelled as “natural flavors” under Regulation EC 1334 2008. According to the European Flavour Association, many EU food brands using thaumatin in 2024 avoided the word “natural” on packaging to prevent legal risk, which is opting instead for terms like plant-basedd” or “from natural sources.” This limitation weakens its competitive positioning against stevia or monk fruit, which can leverage clear “natural sweetener” claims. As per the European Consumer Organisation, consumer surveys have shown that a majority of shoppers associate “natural sweetener” with health benefits, but recognition of E957 as such remains relatively low. Without harmonized guidance from the European Commission on how to communicate thaumatin’s origin, brand owners remain cautious, reducing its visibility and slowing mainstream adoption despite its technical advantages.
The rapid growth of plant-based foods in Europe is a high-value opportunity for the European thaumatin market. Plant proteins from peas, fava beans, and algae often impart strong off notes that deter consumer acceptance. According to ProVeg International, the European plant-based food market saw continued growth in 202,4 with dairy alternatives representing a major share. As per Wageningen University research, many consumers reject plant-based yogurts due to “beany” or “grassy” aftertastes. Thaumatin, used at parts per million levels, effectively suppresses these notes without adding sugar or synthetic ingredients. According to company communications, brands such as Oatly and Alpro have trialed thaumatin in premium lines with reports indicating improved consumer acceptance when bitterness is masked. According to EU guidance on clean label and organic frameworks, E957 may be used in “free from” and certain organic products under specified conditions, opening formulation pathways. This alignment with Europe’s plant-based transition positions thaumatin as a critical enabler of sensory acceptability of ext-generation proteins.
Emerging biotechnological methods offer a promising opportunity to the European thaumatin market. While traditional extraction remains dominant, several European biotech firms are advancing fermentation platforms using non-GMO yeast strains engineered via CRISPR to express thaumatin proteins. According to the European Federation of Biotechnology, several EU-based startups received Horizon Europe funding in 2024 to scale recombinant thaumatin production. For instance, pilot bioreactor trials have demonstrated promising yields that significantly reduce projected costs compared to botanical extraction. Crucially, these platforms aim to avoid transgenic classification under EU Directive 2001/18 by using transient expression systems without foreign DNA integration. The European Food Safety Authority is currently evaluating the first novel food dossier for fermentation-derived thaumatin with a decision expected in late 2025. If approved, this innovation could democratize access, enabling use in mid-tier products and dramatically expanding the addressable market across food, pharma, and oral care sectors.
The Europe Thaumatin Market contends with formidable competition from established and emerging sweeteners that offer lower prices and broader regulatory familiarity. Stevia extracts, though still costly compared to sucrose, benefit from clear “natural” labeling and extensive consumer recognition. Products featuring stevia have shown strong growth in Europe in recent years, while thaumatin-containing items remain niche. Additionally, new synthetic molecules like allulose and rare sugars offer bulk replacement capabilities that thaumatin cannot match due to its protein nature and lack of bulking properties. For instance, replacing sugar with thaumatin significantly increases ingredient costs compared to stevia, which is limiting its use in mass-market formulations. Without significant cost reduction or unique functional claims beyond taste masking, thaumatin risks remaining a marginal player in an increasingly crowded sweetener landscape where price and versatility dominate purchasing decisions.
Despite its technical merits, thaumatin suffers from minimal consumer recognition in Europe, which further challenges the thaumatin market expansion in Europe. Unlike stevia or aspartame, thaumatin is rarely named on packaging; it appears only as “E957” or “sweetener” in ingredient lists, depriving it of brand equity. According to the European Consumer Organisation, surveys conducted in 2024 revealed that consumer awareness of thaumatin remains very low, with only a small fraction of respondents able to identify it by name or associate it with health or naturalness. This invisibility reduces its leverage in clean label marketing, where ingredient transparency drives purchase. As per retail audits, thaumatin is rarely indicated on front-of-pack labeling in sugar-free products across major EU markets such as Germany, France, and Italy. Without coordinated education campaigns or regulatory support for origin labeling, such as “from katemfe fruit,” as thaumatin remains a behind-the-scenes ingredient. This awareness deficit constrains manufacturers' incentive to reformulate, which is creating a cycle where low visibility leads to low adoption, which in turn limits investment in consumer communication and market development.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| CAGR | 4.18% |
| Segments Covered | By Product Type, Application, End User, and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis; Segment-Level Analysis; DROC, PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
| Regions Covered | UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, and the Czech Republic |
| Market Leaders Profiled | KF Specialty Ingredients, Naturex Group, Beneo-Palatinit GmbH, Nutraceutical Group, Parchhem Fine & Specialty Chemicals, Neptune Bio-Innovations, Penta International, Natex, Synerzine, Silver Fern Chemical, and TCI America |
The food-grade segment led the market by holding 55.9% of the regional market share in 2024. Food-grade thaumatin is widely adopted across confectionery, dairy alternatives, and low sugar beverages, where its dual role as a sweetener and flavor modifier aligns with clean label demands. According to the European Commission’s Food Improvement Agents Database, thaumatin (E957) continues to be authorized in the EU with new product launches in 2024 frequently positioned under “no added sugar” or “reduced calorie” claims. The ingredient’s protein nature allows it to be labeled as a “natural flavoring substance” in certain contexts under EU Regulation 1334/2008, which is enhancing its appeal to formulators avoiding synthetic additives. As per sensory research, thaumatin has been shown to improve acceptability in plant-based beverages by masking bitterness, which supports its role in flavor optimization. Furthermore, the EU’s 2023 update to the Nutri-Score algorithm penalizes added sugars more heavily, accelerating reformulation in categories such as breakfast cereals and flavored waters, as these are areas where thaumatin’s synergistic pairing with stevia reduces off notes. These regulatory and sensory drivers solidify food-grade thaumatin as the primary commercial segment.
The pharmaceutical grade segment is the fastest growing product type and is predicted to witness a CAGR of 10.12% over the forecast period in this regional market, owing to the rising pediatric drug development and stringent EU regulations favoring natural taste modifiers in oral formulations. The European Pediatric Regulation mandates age-appropriate formulations, and bitterness masking is critical for compliance. For instance, a majority of liquid antibiotics for children under six now include taste masking agents with thaumati,n recognized as one of the natural options used to improve compliance. Unlike synthetic alternatives, pharmaceutical-grade thaumatin meets Ph Eur monograph standards for purity and endotoxin limits to ensure safety in vulnerable populations. Major manufacturers such as Novartis and Bayer have incorporated thaumatin into taste-masking protocols for oral syrups. Additionally, the European Directorate for the Quality of Medicines approved a new monograph for recombinant thaumatin in 2024, which is paving the way for biotech-derived supplies that meet pharmaceutical quality without botanical supply constraints, further accelerating adoption.
The flavoring agent segment was the leading application segment in the Europe thaumatin market in 2024 and occupied 60.8% of the regional market share. The multifunctional sensory enhancement of flavoring agents is majorly driving the dominance of the segment in the European market. Thaumatin’s primary value in Europe lies not in its sweetness but in its ability to modulate and prolong flavor perception while suppressing bitterness. According to the European Food Safety Authority, thaumatin is widely used in E957-containing products specifically for flavor modification rather than caloric reduction. In plant-based dairy, it enhances vanilla and fruit notes without adding sugar; in nutraceuticals, it masks the metallic aftertaste of iron and zinc. As per sensory research, thaumatin has been shown to extend flavor persistence in yogurt and other applications, supporting consumer preference. Moreover, EU labeling rules allow thaumatin to be declared as a “flavoring” when used below sweetening thresholds, avoiding the “sweetener” designation that some clean label brands avoid. This regulatory and functional flexibility makes it indispensable in complex flavor systems, far beyond simple sugar replacement.
The sweetener segment is the fastest-growing and is predicted to witness a CAGR of 8.12% over the forecast period. The convergence of sugar taxation, health claims, and hybrid sweetening systems is propelling the growth of the sweetener segment in the European market. Countries like the UK and Portugal impose levies on high sugar beverages, pushing manufacturers toward ultra-low-dose sweeteners. Thaumatin is rarely used alone but in synergistic blends with stevia or monk fruit to improve the taste profile. Many new “zero sugar” soft drinks launched in Western Europe in 2024 combined thaumatin with rebaudioside M to reduce licorice aftertaste. Additionally, the European Commission’s 2023 approval of health claims for “reduced sugar intake contributes to dental health” incentivizes substitution. As consumers grow wary of single-molecule sweeteners, multi-component natural systems featuring thaumatin gain traction, which is transforming it from a niche modifier into a core component of next-generation sweetening platforms.
The food and beverage segment occupied the dominating share of 55.5% of the European market in 2024. Food and beverage remain the primary consumption channel for thaumatin due to Europe’s aggressive sugar reduction agenda and consumer demand for clean label indulgence. According to Eurostat, the EU imported significant volumes of low-calorie sweeteners in 2024, with natural high-intensity types showing the fastest growth. Thaumatin features prominently in premium segments such as sugar-free chewing gums (where it enhances mint longevity), organic fruit drinks, and plant-based desserts. As per Mintel product audits, thaumatin has been incorporated into new vegan ice creams in Germany and France for flavor rounding. The EU’s updated guidelines on “free from” claims explicitly permit thaumatin in organic-certified foods when derived from non-GMO sources, opening access to Europe’s 42-billion-euro organic market. Corporate sustainability commitments that further institutionalize its use. This combination of regulatory support, sensory necessity, and premium positioning ensures food and beverage dominance.
The nutraceutical segment is the fastest-growing and is expected to expand at a CAGR of 12.2% over the forecast period. The proliferation of functional foods and dietary supplements targeting gut health, immunity, and cognitive performance is fuelling the growth of the nutraceuticals segment in the European market. Thaumatin enables palatable delivery without compromising clean label integrity. Many EU supplement formulators now use thaumatin in liquid or chewable formats for children and seniors. As per the European Food Safety Authority’s 2023 positive opinion, thaumatin is considered safe in daily use supplements, removing previous dosage hesitations. Additionally, the rise of personalized nutrition kits in Europe increasingly relies on microencapsulated powders where thaumatin masks off notes at ultra-low doses. With the EU nutraceutical market valued at over 28 billion euros and growing, thaumatin’s role as a silent enabler of compliance is accelerating its adoption in this high-value segment.
Germany led the market by accounting for 23.1% of the European market share in 2024. The dominating position of Germany in the European market is attributed to the food science, pharmaceutical manufacturing, and clean-label consumerism. Germany is home to the German Institute of Food Technologies and major corporations like Bayer and Merck. Germany drives both R and D and commercial adoption. According to the Federal Ministry of Food and Agriculture, many new low-sugar food products launched in Germany in 2024 contained natural high-intensity sweeteners, with thaumatin included among them. The country’s strict Leitfaden für die Nährwertkennzeichnung provides clear guidance on E957 usage, reducing formulation uncertainty. Additionally, Germany’s licensed pharmacies frequently compound pediatric syrups with pharmaceutical-grade thaumatin, supported by national reimbursement for taste-masked medications. This blend of scientific rigor, regulatory clarity, and health-conscious consumption makes Germany the market’s innovation anchor.
The United Kingdom is a promising regional segment in the European thaumatin market owing to the Soft Drinks Industry Levy introduced in 2018 and expanded in 2024. According to HM Revenue and Customs, a majority of soft drink manufacturers in the UK reformulated to avoid the higher tax band, with many turning to natural sweetener blends. As per the British Soft Drinks Association, thaumatin’s use in UK beverages has grown in recent years as brands seek clean-label solutions. The UK’s Medicines and Healthcare products Regulatory Agency also supports pediatric formulations with natural excipients, accelerating pharmaceutical adoption. Despite Brexit, the UK retains alignment with EU additive regulations under the Food Additives, Flavourings, Enzymes and Extraction Solvents framework. According to the Food Standards Agency, UK consumers demonstrate high health literacy, with many reading ingredient labels, which further favors transparent, plant-derived ingredients like thaumatin, cementing its role in both food and pharma innovation.
France captured a substantial share of the European thaumatin market in 2024. The growth of France in the European market is attributed to its strong organic sector and “no artificial additives” consumer ethos. According to Agence Bio, France had 2.71 million hectares of organic farmland in 2024, representing about 10.1% of the country’s agricultural land, nd with more than 87,000 certified operators, including farms and processors. The French National Nutrition and Health Program emphasizes improving nutritional quality in school meals, including measures to reduce sugar intake, which drives demand for natural sweetness solutions. Thaumatin is permitted in EU organic products under Council Regulation (EC) No 834/2007 when used as a flavoring, a provision leveraged by brands like Danone and Bjorg. As per consumer research, French shoppers increasingly avoid products with “chemical-sounding” additives, which reflects a strong preference for natural alternatives. Furthermore, France’s Nutri-Score system continues to penalize added sugars, which is creating reformulation pressure.
Switzerland is projected to hold a notable share of the European market over the forecast period due to its class pharmaceutical industry and luxury confectionery sector. Companies like Novartis and Roche use pharmaceutical-grade thaumatin in global pediatric drug portfolios, while Nestlé and Lindt incorporate food-grade thaumatin in sugar-free premium chocolates. According to Swiss Federal Office of Public Health data, Switzerland has consistently promoted safer formulations of pediatric medicines with natural taste modifiers, such as thaumatin, increasingly used to improve palatability. Switzerland’s bilateral agreements with the EU ensure full recognition of E957 approvals, facilitating seamless market access. As per a 2024 GfK survey, 58% of Swiss consumers reported willingness to pay more for clean-label products, including those with “no artificial sweeteners” claims. This convergence of scientific excellence, regulatory harmony, and affluent consumption sustains Switzerland’s outsized influence, justified by the alignment of consumer preferences, regulatory frameworks, and innovation in health-related product development.
The Netherlands is estimated to account for a noteworthy share of the European thaumatin market during the forecast period. The Netherlands serves as Europe’s logistical and innovation gateway for plant-based foods. The Netherlands is home to Wageningen University and over 200 alternative protein startups, making the country a test bed for sensory optimization. For instance, plant-based dairy launches in the Netherlands increasingly use natural taste modulators like thaumatin for bitterness masking. According to the Port of Rotterdam Authority, the port is Europe’s largest entry point for agri-food and natural ingredients, handling a significant share of EU imports and ensuring reliable thaumatin supply. The Netherlands Nutrition Centre actively promotes sugar reduction, aligning with the EU’s Farm to Fork goals. Moreover, Dutch companies such as FrieslandCampina and Unilever incorporate thaumatin in export-ready formulations for pan-European distribution. This role as a hub for innovation, logistics, and regulatory compliance makes the Netherlands a critical amplifier of thaumatin adoption across the continent.
Competition in the Europe Thaumatin Market is characterized by a small number of specialized ingredient suppliers operating in a highly technical, regulation-sensitive niche. Unlike bulk sweeteners, the market does not compete on price but on functional performance, sensory validation, and regulatory compliance. Established players like Tate & Lyle Ingredion and Roquette differentiate through application expertise and formulation support rather than volume. The entry barrier is high due to limited raw material supply and stringency requirements for pharmaceutical use. Competition is further nuanced by the ingredient’s dual identity—as a sweetener under E957 and as a flavoring under EU flavoring regulations—requiring nuanced communication strategies. While global demand remains modest, the European market is disproportionately influential due to its strict standards and innovation in clean-label and plant-based foods. Companies that successfully integrate thaumatin into holistic taste solutions rather than sell it as a standalone additive gain a sustainable advantage. Collaboration with academia, regulatory bodies, and brand owners is essential to navigate labeling constraints and consumer perception gaps in this specialized yet strategically valuable segment.
A few major players in the Europe thaumatin market include
Key players in the Europe Thaumatin Market focus on developing synergistic blends that combine thaumatin with other natural sweeteners to enhance taste profiles and reduce off notes. They invest in sensory science capabilities to generate consumer-validated data supporting reformulation claims. Companies pursue regulatory alignment by ensuring compliance with EU organic, non-GMO, and pediatric excipient standards to broaden application scope. Strategic partnerships with food, pharmaceutical, and plant-based brands enable co-development of tailored solutions rather than commodity supply. Additionally, firms leverage clean label messaging by educating formulators on thaumatin’s botanical origin and GRAS status to overcome labeling ambiguities and strengthen market positioning.
This research report on the Europe thaumatin market has been segmented and sub-segmented based on product type, application, end user, and region.
By Product Type
By Application
By End User
By Region
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region